BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 34917685)

  • 1. Expression of Circulating MicroRNAs and Myokines and Interactions with Serum Osteopontin in Type 2 Diabetic Patients with Moderate and Poor Glycemic Control: A Biochemical and Molecular Study.
    Al-Rawaf HA; Alghadir AH; Gabr SA
    Biomed Res Int; 2021; 2021():7453000. PubMed ID: 34917685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity.
    Komosinska-Vassev K; Gala O; Olczyk K; Jura-Półtorak A; Olczyk P
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32917052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating miR-146a, miR-34a and miR-375 in type 2 diabetes patients, pre-diabetic and normal-glycaemic individuals in relation to β-cell function, insulin resistance and metabolic parameters.
    García-Jacobo RE; Uresti-Rivera EE; Portales-Pérez DP; González-Amaro R; Lara-Ramírez EE; Enciso-Moreno JA; García-Hernández MH
    Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1092-1100. PubMed ID: 31355469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased serum level of miR-146a as sign of chronic inflammation in type 2 diabetic patients.
    Baldeón R L; Weigelt K; de Wit H; Ozcan B; van Oudenaren A; Sempértegui F; Sijbrands E; Grosse L; Freire W; Drexhage HA; Leenen PJ
    PLoS One; 2014; 9(12):e115209. PubMed ID: 25500583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rs2910164 variant is associated with reduced miR-146a expression but not cytokine levels in patients with type 2 diabetes.
    Alipoor B; Ghaedi H; Meshkani R; Omrani MD; Sharifi Z; Golmohammadi T
    J Endocrinol Invest; 2018 May; 41(5):557-566. PubMed ID: 29058209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum adropin levels are decreased in Chinese type 2 diabetic patients and negatively correlated with body mass index.
    Zang H; Jiang F; Cheng X; Xu H; Hu X
    Endocr J; 2018 Jul; 65(7):685-691. PubMed ID: 29669965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating serum microRNAs including senescent miR-31-5p are associated with incident fragility fractures in older postmenopausal women with type 2 diabetes mellitus.
    Heilmeier U; Hackl M; Schroeder F; Torabi S; Kapoor P; Vierlinger K; Eiriksdottir G; Gudmundsson EF; Harris TB; Gudnason V; Link TM; Grillari J; Schwartz AV
    Bone; 2022 May; 158():116308. PubMed ID: 35066213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNA-122, microRNA-126-3p and microRNA-146a are associated with inflammation in patients with pre-diabetes and type 2 diabetes mellitus: A case control study.
    Zeinali F; Aghaei Zarch SM; Jahan-Mihan A; Kalantar SM; Vahidi Mehrjardi MY; Fallahzadeh H; Hosseinzadeh M; Rahmanian M; Mozaffari-Khosravi H
    PLoS One; 2021; 16(6):e0251697. PubMed ID: 34077450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D Deficiency and Molecular Changes in Circulating MicroRNAs in Older Adults with Lower Back Pain.
    Al-Rawaf HA; Gabr SA; Alghadir AH
    Pain Res Manag; 2021; 2021():6662651. PubMed ID: 34055120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNA-155 is associated with insulin resistance in chronic hepatitis C patients.
    El Samaloty NM; Hassan ZA; Hefny ZM; Abdelaziz DHA
    Arab J Gastroenterol; 2019 Mar; 20(1):1-7. PubMed ID: 30852102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered levels of circulating cytokines and microRNAs in lean and obese individuals with prediabetes and type 2 diabetes.
    Nunez Lopez YO; Garufi G; Seyhan AA
    Mol Biosyst; 2016 Dec; 13(1):106-121. PubMed ID: 27869909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Potential Relationship Between Serum Irisin Concentration With Inflammatory Cytokines, Oxidative Stress Biomarkers, Glycemic Indices and Lipid Profiles in Obese Patients With Type 2 Diabetes Mellitus: A Pilot Study.
    Khajebishak Y; Faghfouri AH; Soleimani A; Ilaei S; Peyrovi S; Madani S; Payahoo L
    J ASEAN Fed Endocr Soc; 2023; 38(1):45-51. PubMed ID: 37252420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D supplementation improves SIRT1, Irisin, and glucose indices in overweight or obese type 2 diabetic patients: a double-blind randomized placebo-controlled clinical trial.
    Safarpour P; Daneshi-Maskooni M; Vafa M; Nourbakhsh M; Janani L; Maddah M; Amiri FS; Mohammadi F; Sadeghi H
    BMC Fam Pract; 2020 Feb; 21(1):26. PubMed ID: 32033527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma osteopontin levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
    Wang C; He M; Peng J; Li S; Long M; Chen W; Liu D; Yang G; Zhang L
    Cytokine; 2020 Jan; 125():154837. PubMed ID: 31514105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization.
    Ortega FJ; Mercader JM; Moreno-Navarrete JM; Rovira O; Guerra E; Esteve E; Xifra G; Martínez C; Ricart W; Rieusset J; Rome S; Karczewska-Kupczewska M; Straczkowski M; Fernández-Real JM
    Diabetes Care; 2014; 37(5):1375-83. PubMed ID: 24478399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adropin and irisin levels in relation to nutrition, body composition, and insulin resistance in patients with end-stage renal disease on chronic hemodialysis and peritoneal dialysis.
    Kałużna M; Hoppe K; Schwermer K; Ibrahim AY; Pawlaczyk K; Ziemnicka K
    Pol Arch Med Wewn; 2016 Jul; 126(7-8):474-82. PubMed ID: 27452672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating IRAPe, Irisin, and IL-34 in Relation to Insulin Resistance in Patients With Type 2 Diabetes.
    Mostafa TM; El-Gharbawy NM; Werida RH
    Clin Ther; 2021 Jul; 43(7):e230-e240. PubMed ID: 34103176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy.
    Zou HL; Wang Y; Gang Q; Zhang Y; Sun Y
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1159-1166. PubMed ID: 28382439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated miR-155 expression in peripheral blood mononuclear cells from patients with type 2 diabetes.
    Corral-Fernández NE; Salgado-Bustamante M; Martínez-Leija ME; Cortez-Espinosa N; García-Hernández MH; Reynaga-Hernández E; Quezada-Calvillo R; Portales-Pérez DP
    Exp Clin Endocrinol Diabetes; 2013 Jun; 121(6):347-53. PubMed ID: 23616185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From Euglycemia to Recent Onset of Type 2 Diabetes Mellitus: A Proof-of-Concept Study on Circulating microRNA Profiling Reveals Distinct, and Early microRNA Signatures.
    Greco M; Mirabelli M; Salatino A; Accattato F; Aiello V; Brunetti FS; Chiefari E; Pullano SA; Fiorillo AS; Foti DP; Brunetti A
    Diagnostics (Basel); 2023 Jul; 13(14):. PubMed ID: 37510186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.